ERBB2 and breast carcinoma: Gallen International Expert Consensus proposed a method for classifying breast cancer into 4 subtypes using immunostaining: Luminal A, Luminal B, Human Epidermal growth factor Receptor 2 (HER2) positive and triple negative- type breast cancer (TNBC) [8].